SEC FORM 4
$168,944.70
UNITED THERAPEUTICS Corp (UTHR)
Sale of 309 shares at $546.7466 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Oct 2, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →